ERBB2 and breast carcinoma: <b>Background/Objectives:</b> While human epidermal growth factor receptor 2 (HER2) immunohistochemistry (IHC) is pivotal for breast cancer management, its reliance on additional tissue processing beyond routine H&E staining remains a clinical burden.